The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Biovet JSC's share price is лв0.00.
Biovet JSC's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2016 was лв33.52. Hence, Biovet JSC's PS Ratio for today is 0.00.
The historical rank and industry rank for Biovet JSC's PS Ratio or its related term are showing as below:
LTS:0III'
s PS Ratio Range Over the Past 10 Years
Min: 0.33 Med: 0.43 Max: 1.8
Current: 0.43
During the past 8 years, Biovet JSC's highest PS Ratio was 1.80. The lowest was 0.33. And the median was 0.43.
LTS:0III's PS Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.3
vs LTS:0III: 0.43
During the past 12 months, the average Revenue per Share Growth Rate of Biovet JSC was 13.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.60% per year.
During the past 8 years, Biovet JSC's highest 3-Year average Revenue per Share Growth Rate was 16.30% per year. The lowest was 4.20% per year. And the median was 12.30% per year.
Back to Basics: PS Ratio
Biovet JSC (LTS:0III) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Biovet JSC PS Ratio Related Terms
Biovet JSC PS Ratio Historical Data
* Premium members only.
The historical data trend for Biovet JSC's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Biovet JSC's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biovet JSC PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Biovet JSC's PS Ratio distribution charts can be found below:
* The bar in red indicates where Biovet JSC's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Biovet JSC's Share Price of today is лв0.00. Biovet JSC's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was лв33.52.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Biovet JSC (LTS:0III) has a PS Ratio of 0.00 as of Jul. 12, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Biovet JSC and its competitors. Over the past decade, Biovet JSC's PS Ratio has ranged from 0.33 to 1.80.
Is Biovet JSC's PS Ratio too high?
Biovet JSC's current PS Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 1.80.
How does Biovet JSC's PS Ratio compare to ADMP and AGRX?
Biovet JSC's PS Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median PS Ratio is 2.30. Historically, Biovet JSC's own PS Ratio has ranged from 0.33 to 1.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.30, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Biovet JSC and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biovet JSC's current PS Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current PS Ratio of 0.00. The current PS Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current PS Ratio is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0III has been successfully added to your 